108 related articles for article (PubMed ID: 30720033)
1. Network-based approach to identify principal isoforms among four cancer types.
Ma J; Wang J; Ghoraie LS; Men X; Haibe-Kains B; Dai P
Mol Omics; 2019 Apr; 15(2):117-129. PubMed ID: 30720033
[TBL] [Abstract][Full Text] [Related]
2. A method for identifying discriminative isoform-specific peptides for clinical proteomics application.
Zhang F; Chen JY
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):522. PubMed ID: 27557076
[TBL] [Abstract][Full Text] [Related]
3. Network-Based Isoform Quantification with RNA-Seq Data for Cancer Transcriptome Analysis.
Zhang W; Chang JW; Lin L; Minn K; Wu B; Chien J; Yong J; Zheng H; Kuang R
PLoS Comput Biol; 2015 Dec; 11(12):e1004465. PubMed ID: 26699225
[TBL] [Abstract][Full Text] [Related]
4. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
Zinda MJ; Johnson MA; Paul JD; Horn C; Konicek BW; Lu ZH; Sandusky G; Thomas JE; Neubauer BL; Lai MT; Graff JR
Clin Cancer Res; 2001 Aug; 7(8):2475-9. PubMed ID: 11489829
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide isoform-level analysis reveals tumor-specific isoforms for lung adenocarcinoma diagnosis and prognosis.
Zhuhong H; Zhenyu B; Xiangyuan C; Tingzhen X; Libin S
Cancer Genet; 2019 Jan; 230():58-65. PubMed ID: 30470588
[TBL] [Abstract][Full Text] [Related]
6. Network-based method for drug target discovery at the isoform level.
Ma J; Wang J; Ghoraie LS; Men X; Liu L; Dai P
Sci Rep; 2019 Sep; 9(1):13868. PubMed ID: 31554914
[TBL] [Abstract][Full Text] [Related]
7. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
[TBL] [Abstract][Full Text] [Related]
8. Functional Networks of Highest-Connected Splice Isoforms: From The Chromosome 17 Human Proteome Project.
Li HD; Menon R; Govindarajoo B; Panwar B; Zhang Y; Omenn GS; Guan Y
J Proteome Res; 2015 Sep; 14(9):3484-91. PubMed ID: 26216192
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic impact of transcript isoform switching in 1,209 cancer samples covering 27 cancer types using an isoform-specific interaction network.
Kahraman A; Karakulak T; Szklarczyk D; von Mering C
Sci Rep; 2020 Sep; 10(1):14453. PubMed ID: 32879328
[TBL] [Abstract][Full Text] [Related]
10. Integration of cancer gene co-expression network and metabolic network to uncover potential cancer drug targets.
Chen J; Ma M; Shen N; Xi JJ; Tian W
J Proteome Res; 2013 Jun; 12(6):2354-64. PubMed ID: 23590569
[TBL] [Abstract][Full Text] [Related]
11. Expression dynamics of periodic transcripts during cancer cell cycle progression and their correlation with anticancer drug sensitivity.
Li CX; Wang JS; Wang WN; Xu DK; Zhou YT; Sun FZ; Li YQ; Guo FZ; Ma JL; Zhang XY; Chang MJ; Xu BH; Ma F; Qian HL
Mil Med Res; 2022 Dec; 9(1):71. PubMed ID: 36529792
[TBL] [Abstract][Full Text] [Related]
12. Molecular assay to generate expression profile of eight estrogen receptor alpha isoform mRNA copy numbers in picogram amounts of total RNA from breast cancer tissues.
Poola I
Anal Biochem; 2003 Mar; 314(2):217-26. PubMed ID: 12654308
[TBL] [Abstract][Full Text] [Related]
13. BARD1: an independent predictor of survival in non-small cell lung cancer.
Zhang YQ; Bianco A; Malkinson AM; Leoni VP; Frau G; De Rosa N; André PA; Versace R; Boulvain M; Laurent GJ; Atzori L; Irminger-Finger I
Int J Cancer; 2012 Jul; 131(1):83-94. PubMed ID: 21815143
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
Malentacchi F; Simi L; Nannelli C; Andreani M; Janni A; Pastorekova S; Orlando C
Lung Cancer; 2009 Jun; 64(3):271-6. PubMed ID: 19022520
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic BARD1 isoforms expressed in gynecological cancers.
Li L; Ryser S; Dizin E; Pils D; Krainer M; Jefford CE; Bertoni F; Zeillinger R; Irminger-Finger I
Cancer Res; 2007 Dec; 67(24):11876-85. PubMed ID: 18089818
[TBL] [Abstract][Full Text] [Related]
16. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
17. Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer.
Aversa R; Sorrentino A; Esposito R; Ambrosio MR; Amato A; Zambelli A; Ciccodicola A; D'Apice L; Costa V
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784191
[TBL] [Abstract][Full Text] [Related]
18. Integrative genomic data mining for discovery of potential blood-borne biomarkers for early diagnosis of cancer.
Yang Y; Pospisil P; Iyer LK; Adelstein SJ; Kassis AI
PLoS One; 2008; 3(11):e3661. PubMed ID: 18987750
[TBL] [Abstract][Full Text] [Related]
19. Aberrant DNA methylation defines isoform usage in cancer, with functional implications.
Chen YC; Elnitski L
PLoS Comput Biol; 2019 Jul; 15(7):e1007095. PubMed ID: 31329578
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive expression-based isoform biomarkers predictive of drug responses based on isoform co-expression networks and clinical data.
Ma J; Wang J; Ghoraie LS; Men X; Chen R; Dai P
Genomics; 2020 Jan; 112(1):647-658. PubMed ID: 31029864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
